Report Code: A06759 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Tapentadol is a dual mode analgesic that performs both the actions of being a norepinephrine reuptake inhibitor as well as a mu-opioid receptor antagonist. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is utilized for the treatment of moderate to severe pain for chronic and acute musculoskeletal pain. It is often used to ease pain, which cannot be managed with other types of analgesics and for controlling the pain of diabetic neuropathy when round-the-clock analgesics are required.
The global tapentadol market has been severely affected by the outbreak of the COVID-19 pandemic all over the world.
Surge in prevalence of chronic disorders, such as chronic musculoskeletal pain, is a key factor fueling the demand for taentadol across the globe. Tapentadol is further used for the treatment of moderate to severe acute pain. The potency of this treatment lies somewhere between that of morphine and tramadol. Despite the lower occurrence of side effects, its analgesics efficacy is comparable to that of oxycodone. In addition, alarming rise in number of patients suffering from diabetes significantly contributes toward the growth of the global tapentadol market.
Surge in demand for analgesics is expected to increase the overall demand for tapentadol. In addition, rise in need for over-the-counter painkillers is expected to boost the demand for tapentadol, thereby driving the growth of the global tapentadol market.
However, tapentadol is known to have adverse side effects. It may impair cognitive and physical abilities and should not be used when operating heavy machinery, especially during initial treatment. Dizziness, nausea, constipation, and central nervous system sedation are common side effects of tapentadol. Consumption of tapentadol further increases the risk of seizure and should be administered to epileptic patients with extreme cautious. Moreover, it is not recommended for treatment of women during or immediately before labor and delivery. In addition to such adverse effects, stringent government regulations for its controlled use and availability of substitutes hamper the growth of the global tapentadol market.
The North America region accounts for the largest share of the tapentadol market, owing to high demand in countries such as the U.S. and Canada. The market in the Asia-Pacific region is expected to grow steadily with high demand and presence of several manufacturers of pharmaceutical products in the nations such as India and China.
Key benefits of the report
Questions answered in the global tapentadol market research report:
Tapentadol Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Application |
|
By Industry Vertical |
|
By Region |
|
Key Market Players | IPCA Laboratories Ltd., Johnson & Johnson Pharmaceutical Research & Development, Ranbaxy Laboratories Ltd., Cadila Pharmaceuticals Ltd., Lupin Laboratories Ltd., and Aristo Pharmaceuticals Pvt. Ltd., |
Other Key Market Players | Suzhou Shang Enda Biotechnology Ltd, Hangzhou Qichuang Chemical Co.,Ltd, Shandong Chuangxin Pharmaceutical |
Loading Table Of Content...
Start reading.
This Report and over 71,321+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers